Department of Pharmacology , Sri Balaji Vidyapeeth (Deemed-to-be-University), Mahatma Gandhi Medical College and Research Institute (MGMCRI) , Pondicherry , India
Auto-generated profile, based on publicly available information
Swaliha Chediyankandy
Department of Pharmacology , Sri Balaji Vidyapeeth (Deemed-to-be-University), Mahatma Gandhi Medical College and Research Institute (MGMCRI) , Pondicherry , India
Objectives: In this study, the hydroalcoholic extract of entire Begonia malabarica plant was screened to identify its specific phytochemical groups and in vitro cytotoxic potential against HepG2 (Human Hepatocellular carcinoma) cell lines. Methods: Annexin V/PI Apoptotic assay and the MTT assay, were employed in this study. MTT assay was used to evaluate in vitro cytotoxic potential of B. malabarica extract against the HepG2 cell line. The Annexin V/PI Apoptotic assay was performed to estimate the proportion of cells undergoing apoptosis. The results were compared with doxorubicin as standard. Results: The MTT assay found that at highest concentration of 500 μg/mL, the hydroalcoholic extract of B. malabarica reduced cell viability to 24.17 %, while doxorubicin treated cell showed cell viability to 4.8 % at highest concentration of 100 μg/mL. Flow cytometry based Annexin V analysis revealed that B. malabarica extract induced pronounced apoptosis in HepG2 cells, marked by a dominant late apoptotic population (70.56 %) and dead cells (22.17 %), with minimal early apoptotic (0.04 %) and viable cells (7.23 %). The percentage of cells undergone late apoptosis was identical to standard drug doxorubicin (71.2 %). These results suggest a late apoptotic response, potentially involving mitochondrial disruption, oxidative stress, or caspase activation. Conclusions: These findings highlight the presence of bioactive compounds in B. malabarica that can modulate cell death pathways, supporting its potential as a potential anti-cancer agent. However, more research can help in better understanding of the role of this plant as a potential new source of cancer therapy and uncover previously unknown pharmacological activities and properties.